ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014